These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30689936)

  • 21. Hyaluronan metabolism enhanced during epidermal differentiation is suppressed by vitamin C.
    Hämäläinen L; Kärkkäinen E; Takabe P; Rauhala L; Bart G; Kärnä R; Pasonen-Seppänen S; Oikari S; Tammi MI; Tammi RH
    Br J Dermatol; 2018 Sep; 179(3):651-661. PubMed ID: 29405260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic steatosis, fibrosis, and cancer in elderly cadavers.
    Mak KM; Kwong AJ; Chu E; Hoo NM
    Anat Rec (Hoboken); 2012 Jan; 295(1):40-50. PubMed ID: 22139908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma in noncirrhotic livers is associated with steatosis rather than steatohepatitis: potential implications for pathogenesis.
    van Meer S; van Erpecum KJ; Sprengers D; Klümpen HJ; Jansen PL; Ijzermans JN; Siersema PD; de Man RA; Verheij J
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):955-62. PubMed ID: 27196679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study.
    Alexander J; Torbenson M; Wu TT; Yeh MM
    J Gastroenterol Hepatol; 2013 May; 28(5):848-54. PubMed ID: 23302015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of obesity on liver histology.
    Goodman ZD
    Clin Liver Dis; 2014 Feb; 18(1):33-40. PubMed ID: 24274863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockout of hyaluronan synthase 1, but not 3, impairs formation of the retrocalcaneal bursa.
    Sikes KJ; Renner K; Li J; Grande-Allen KJ; Connell JP; Cali V; Midura RJ; Sandy JD; Plaas A; Wang VM
    J Orthop Res; 2018 Oct; 36(10):2622-2632. PubMed ID: 29672913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan.
    Akuta N; Kawamura Y; Suzuki F; Saitoh S; Arase Y; Kunimoto H; Sorin Y; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Suzuki Y; Kobayashi M; Ikeda K; Kumada H
    Hepatol Int; 2016 Jul; 10(4):647-56. PubMed ID: 27074850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver pathology in obesity.
    Suriawinata A; Fiel MI
    Semin Liver Dis; 2004 Nov; 24(4):363-70. PubMed ID: 15605304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological features of hepatocellular carcinoma with fatty change: Tumors with macrovesicular steatosis have better prognosis and aberrant expression patterns of perilipin and adipophilin.
    Kubota N; Ojima H; Hatano M; Yamazaki K; Masugi Y; Tsujikawa H; Fujii-Nishimura Y; Ueno A; Kurebayashi Y; Shinoda M; Kitago M; Abe Y; Kitagawa Y; Sakamoto M
    Pathol Int; 2020 Apr; 70(4):199-209. PubMed ID: 31930673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency.
    Toriguchi K; Hatano E; Tanabe K; Takemoto K; Nakamura K; Koyama Y; Seo S; Taura K; Uemoto S
    J Gastroenterol Hepatol; 2014 May; 29(5):1109-18. PubMed ID: 24329600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Systemic Hyaluronan Synthesis Exacerbates Murine Hepatic Carcinogenesis.
    Mikami K; Endo T; Sawada N; Igarashi GO; Kimura M; Sakuraba H; Fukuda S
    In Vivo; 2018; 32(2):273-278. PubMed ID: 29475909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-Type-Specific Expression of Hyaluronan Synthases HAS2 and HAS3 Promotes Goblet Cell Hyperplasia in Allergic Airway Inflammation.
    Lee SN; Yoon SA; Song JM; Kim HC; Cho HJ; Choi AMK; Yoon JH
    Am J Respir Cell Mol Biol; 2022 Sep; 67(3):360-374. PubMed ID: 35679095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment.
    Agosti P; Sabbà C; Mazzocca A
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):607-617. PubMed ID: 29197664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lipid droplet-associated proteins. Importance in steatosis, steatohepatitis and hepatocarcinogenesis].
    Straub BK
    Pathologe; 2015 Nov; 36 Suppl 2():146-52. PubMed ID: 26400566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human hyaluronic acid synthase-1 promotes malignant transformation via epithelial-to-mesenchymal transition, micronucleation and centrosome abnormalities.
    Nguyen N; Kumar A; Chacko S; Ouellette RJ; Ghosh A
    Cell Commun Signal; 2017 Nov; 15(1):48. PubMed ID: 29137675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronan synthase 3 promotes plaque inflammation and atheroprogression.
    Homann S; Grandoch M; Kiene LS; Podsvyadek Y; Feldmann K; Rabausch B; Nagy N; Lehr S; Kretschmer I; Oberhuber A; Bollyky P; Fischer JW
    Matrix Biol; 2018 Mar; 66():67-80. PubMed ID: 28987865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Jou J; Choi SS; Diehl AM
    Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.
    Bahcecioglu IH; Yalniz M; Ataseven H; Ilhan N; Ozercan IH; Seckin D; Sahin K
    Hepatogastroenterology; 2005; 52(65):1549-53. PubMed ID: 16201116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of hyaluronan synthase 3 deficiency after acute vs chronic liver injury in mice.
    McCracken JM; Jiang L; Deshpande KT; O'Neil MF; Pritchard MT
    Fibrogenesis Tissue Repair; 2016; 9():4. PubMed ID: 27042213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.
    Ma WL; Lai HC; Yeh S; Cai X; Chang C
    Endocr Relat Cancer; 2014 Jun; 21(3):R165-82. PubMed ID: 24424503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.